Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Oral Oncol ; 50(9): 869-76, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-24998139

RESUMO

OBJECTIVES: The standard concurrent radiotherapy and chemotherapy regimens for patients with oropharyngeal cancer are highly toxic. Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) has recently emerged as a distinct biological and clinical entity with improved response to treatment and prognosis. A tailored therapeutic approach is needed to optimize patient care. The aim of our study was to investigate the impact of HPV and smoking status on early toxicities (primarily mucositis) associated with concurrent chemotherapy and radiotherapy in patients with OPSCC. MATERIALS AND METHODS: We retrospectively evaluated 72 consecutive patients with OPSCC and known HPV status treated with concurrent radiotherapy and chemotherapy at our institution. Treatment-related toxicities were stratified by smoking and HPV status and compared using univariate and multivariate logistic regression. RESULTS: HPV-positive patients had a 6.86-fold increase in the risk of having severe, grade 3-4 mucositis. This effect was preserved after adjusting for patient smoking status, nodal stage, radiotherapy technique and radiotherapy maximum dose. Additionally, HPV status had significant effect on the objective weight loss during treatment and at three months after treatment. Consistently, non-smokers had a significant 2.70-fold increase in the risk of developing severe mucositis. CONCLUSION: Risk factors for OPSCC modify the incidence of treatment-related early toxicities, with HPV-positive and non-smoking status correlating with increased risk of high grade mucositis and associated outcomes. Retrospective single-institution studies need to be interpreted cautiously. However, this finding is important to consider when designing therapeutic strategies for HPV-positive patients and merits further investigation in prospective clinical trials.


Assuntos
Alphapapillomavirus/isolamento & purificação , Mucosite/etiologia , Neoplasias Orofaríngeas/tratamento farmacológico , Neoplasias Orofaríngeas/radioterapia , Fumar , Adulto , Idoso , Idoso de 80 Anos ou mais , Antineoplásicos/efeitos adversos , Terapia Combinada , Intervalo Livre de Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Cooperação do Paciente , Radioterapia/efeitos adversos , Estudos Retrospectivos , Resultado do Tratamento
2.
Phys Rev Lett ; 84(19): 4405-8, 2000 May 08.
Artigo em Inglês | MEDLINE | ID: mdl-10990697

RESUMO

Chiral symmetry breaking in stirred crystallization of sodium chlorate ( NaClO3) occurs via the production of secondary crystals from a single "mother crystal." Martin, Tharrington, and Wu [Phys. Rev. Lett. 77, 2826 (1996)] investigated this phenomenon and concluded that it was mechanical crushing of a crystal by the stir bar, not convection, that produces secondary crystals from a single crystal. Here we report the generation of secondary crystals of sodium chlorate when a saturated solution of sodium chlorate is simply made to flow over a sodium bromate ( NaBrO3) crystal. This clearly shows that fluid flows alone can generate and disperse secondary nuclei.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA